Skip to main content
The ARK Venture Fund Is Proud To Be A Part Of OpenAI’s Latest Funding Round!
ARKVX Participated In OpenAI's Latest Round
Learn More

Looking For Our European Funds?

Click Here
About How To Invest
ARK Invest logo
You Are Entering ark-funds.com

Please read this page before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which the funds are authorized for sale. By proceeding, you are confirming you understand that ARK Investment Management LLC or its affiliates (collectively, “ARK”), makes no representation that the content of the website is appropriate for use in all locations, or that the transactions, securities, products, instruments or services discussed at this website are available or appropriate for sale or use in all jurisdictions or countries, or by all investors or counterparties.


This section of the website is operated by ARK, and is only directed at U.S. investors or those otherwise authorized to conduct investment business in the U.S. Persons resident in territories other than the United States should not access this website.


It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. Certain of the funds and advisory products and services referenced on this website may be managed or offered/provided by affiliates of ARK. Additionally, certain of the funds described in the following pages may be marketed in certain jurisdictions only. Any entity forwarding the material or information contained on this website, which is produced by ARK in the United States, to other parties takes full responsibility for ensuring compliance with applicable securities laws in connection with its distribution.


This website only includes information on those funds that are registered for sale in the United States.


By accessing this website, you are confirming that you agree to the Terms and Conditions of this website and that you are resident in the United States or those otherwise authorized to conduct investment business in the U.S.


The contents of this website have been prepared for informational purposes only without regard to the investment objectives, financial situation, or means of any particular person or entity, and ARK is not soliciting any action based upon them. No information included on this website is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any fund; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. ARK recommends that you seek independent financial and tax advice before making any investment decisions. Investment in any of the funds described in this website should only be made on the basis of the terms and conditions of the most recent applicable offering documents (including any relevant supplements).


All material has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. Some of the content on this website may contain certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. From time to time, ARK may also make additional features available to users on this website on such terms and conditions as may be set forth in a modification to this Agreement or otherwise on the ARK website.


The ARK ETF Trust Thematic Actively Managed ETF’s are distributed by Foreside Fund Services, LLC (“Foreside“), which is not affiliated with ARK Investment Management LLC. Check the background of Foreside on FINRA’s BrokerCheck.


You should carefully consider the investment objective, risks, charges and expenses of a Fund before investing. A Fund’s prospectus and summary prospectus contain this and other important information about a Fund, which can be obtained by clicking the corresponding link or dialing the indicated phone number herein. Please read the appropriate prospectus carefully before investing.


GENERAL RISK FACTORS


You should be aware that past performance is not a reliable indicator of future performance. Please note that the price of units or shares and the income from them can fall as well as rise and you may not get back the amount originally invested. Income receivable may vary from the amount of income projected at the time of making the investment.


Exchange rate fluctuations may affect the value of an investment and any income derived from it.


If you exercise any right to redeem, you may not get back the amount initially invested if the unit or share price has fallen since you invested. Deductions for charges and expenses, particularly the initial charge (if any), are not made uniformly throughout the life of the investment, so if you redeem out of the investment during the early years, you may not get back the amount invested.


There can be no guarantee that the tax position or proposed tax position prevailing at the time of an investment will not change. Dividends and capital gains on securities issued in the relevant funds may be subject to withholding taxes imposed by the countries in which each particular fund invests.


The offering documents for the investment funds contain important information summarizing the relevant risk factors pertaining to the investment or relevant funds. Please note, however, that no summary of risk factors is exhaustive, and there may be other risks that could affect your investment. For your own benefit and protection you should read the most recent offering documents (including any relevant supplements) carefully before investing. If you do not understand any point please ask for further information.


The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject any of the funds described herein, ARK (including its affiliates) or any of their products or services to any registration, licensing or other authorization requirement within such jurisdiction or country. Nothing on this website shall be considered a solicitation to buy or sell a security, product or service (including advisory service) to any person.


HYPERLINKS


ARK does not recommend or endorse and accepts no responsibility for the content of any website not operated by ARK which you may visit by following a link from this website. You acknowledge and agree that neither ARK nor any of its affiliates is responsible for the availability of such third-party websites or resources, does not endorse, approve, investigate or verify, and is not responsible or liable for any content, advertising, products, or other materials on or available from such websites or resources. You further agree that neither ARK nor any of its affiliates shall be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, products or services available on such external websites or resources. These links are provided as a convenience and solely for informational purposes. ARK is not making any recommendation to invest in, purchase, or sell any securities or other products or services offered on the linked websites, nor has ARK sought to verify or confirm the information contained in the linked websites. Accordingly, ARK disclaims any responsibility for the linked websites.


No other website, without the prior written permission of ARK, is authorized to link to any part of this website.


COOKIES


ARK uses cookies for collecting user information from certain pages of this website. A cookie is a file that is stored on the hard disk of a computer by the web browser on a computer. It contains information sent by the website that a user has visited. A cookie identifies users and can store information about them and their use of a website. ARK uses cookies to keep track of user activity, which allows ARK to identify which areas of the website are more interesting to the users so that improvements can be made to this website.


ARK expressly reserves the right to monitor any use of this website.


I confirm that I have read and accept the Terms and Conditions of using this website and that I am based in the United States or those otherwise authorized to conduct investment business in the United States.

Ark Logo

Select Your Region

CONTINUE TO U.S. SITE VISIT EUROPEAN SITE

Q3 2024: Commentary From ARK’s CIO

Oct 16, 2024
11 min read

Click here to download the PDF version.

Broad-based global equity indexes1 appreciated in the third quarter as markets anticipated and reacted to a shift in the U.S. Federal Reserve’s (Fed) policy, beginning with a 50 basis point2 cut in September. While the consensus forecast is for a soft landing, ARK still expects that a loss of pricing power will force corporations into employment cutbacks, perpetuating the rolling recession3  that began in the spring of 2022 when the Fed started hiking interest rates by 22-fold in little more than a year’s time. In response, housing, autos, commercial real estate, and capital spending have capitulated, while inventories continue to build and small business optimism, as measured by the NFIB (National Federation of Independent Business), hovered at lows not seen since the 2008-09 global financial crisis (GFC). In our view, the Five Innovation Platforms4  around which ARK has centered its research and investing could play an outsized role in pulling the economy out of this rolling recession, salvaging corporate margins as inflation gives way to deflation in many sectors during the next few years.

Signaling recession in July, the employment report triggered the Sahm Rule, as the three-month moving average of the U.S. unemployment rate rose 50 basis points above its lowest point in the last 12 months, historically an indicator that the economy has been in recession for three months. Underscoring labor market weakness, for the twelve months ended March 2024, the Bureau of Labor Statistics revised employment down by 818,000, the largest downward revision since 2009, taking the average growth in monthly payrolls down from 242,000 to 174,000 jobs per month. Moreover, after a surge during the post-COVID "Great Resignation", quit rates have reversed sharply, taking the year-over-year growth in wages for job changers down from 16% to 7%.

ARK’s research suggests that the economy has been undergoing rolling recessions. Supporting that point of view are the following indicators:

  • The auto industry faced significant challenges during the COVID-19 pandemic and, while sales did enter a V-shaped recovery in 2021, current unit sales are annualizing at a 15.8 million5 rate, well below the pre-COVID range of 17-18 million units. In the early days of the pandemic, autos accounted for roughly one-third of the inflation spike. Now, used car prices are down 5% on a year-over-year basis and have dropped 21% below peak prices.6
  • Housing metrics like median prices, housing starts, and affordability also are sending troubling signals. At 3.9 million units, the number of existing home sales is not far above levels last seen during the global housing crisis.7 At the same time, the historically high number of apartment units currently under construction suggests that rents will push inflation into much lower-than-expected territory during the next year.
  • Many global company bellwethers have corroborated the weakness in economic activity, reporting declines in revenues on a year-over-year basis in their most recent quarters. Notably, against “easy” comparisons a year ago, the revenue declines at 3M (-0.4%), UPS (-1.1%), Dow (-4.4%), Thermo Fisher (-1.4%), Texas Instruments (-15.6%), and FedEx (-0.5%) have surprised on the low side of expectations. Other bellwethers like Kraft-Heinz (-3.6%), Cisco (-10.3%), Caterpillar (-3.6%), and Procter & Gamble (-0.1%) also have reported year-over-year revenue declines, underscoring the widespread weakness in economic activity.
  • After boosting profitability with higher prices during the supply-chain-related bottlenecks in 2021-22, and again as unit growth disappointed in 2023, corporations now seem to be losing pricing power, to the detriment of profit margins. Already, companies like Amazon, Nike, Starbucks, and McDonald’s have launched discount campaigns to win back consumers. As measured by Bloomberg, the S&P 500's gross margin declined from 34.5% on average during the past five years to 33.4% during the third quarter of 2024. In our view, this setback will intensify until the Fed cuts interest rates significantly and/or companies harness innovation like artificial intelligence aggressively, not only to drive productivity growth but also to create new products and services that replace legacy solutions. To limit the damage to margins in the interim, companies that hoarded employees during post-COVID labor shortages are likely to lay them off during the next year, further allaying the Fed’s concern about underlying inflation. As a result, nominal activity could weaken beyond the recent soft spots associated with housing, autos, and other big-ticket purchases, forcing more price cuts and margin compression.
  • As measured by the National Federation of Independent Business (NFIB), Small Business Optimism in the US is in recession territory, lower not only than that seen during the COVID recession and the saving and loans crisis, but also at level experienced during the GFC.8 Small businesses are the primary drivers of job creation, so plummeting confidence suggests that the labor market could be much weaker than headline figures suggest.
  • M29 growth turned negative on a year-over-year basis from December 2022 through March 2024 and, at 2.0%, is still weak by historical standards. Should the correlation between the Consumer Price Index10 (CPI) and 18-month leading M2 growth hold steady, CPI could turn negative next year, as it did in 2014, 2015, and 2020. 
  • The ratio of the Commodity Research Bureau (CRB) Metals price index to the Gold price index has dropped below its lows during the GFC in 2008-2009 and the COVID crisis. Until the Fed started raising rates in 2022, this ratio had been correlated closely with long-term interest rates. If this relationship were to revert to normal, interest rates could collapse, or metals prices could rise significantly, or some combination of both. Thus far, interest rates seem to be holding sway.
  • Current high-yield spreads11 are remarkably narrow compared to long-term averages, indicating that credit markets do not perceive credit or deflationary risks. Perhaps abundant liquidity is chasing yield and distorting those spreads, masking underlying risks that would be more apparent otherwise.

While the Fed was focused on squelching inflation with higher interest rates, the bond market was signaling trouble ahead. From March 2021 to July 2023, the yield curve12 inverted from +159 basis points to -108 basis points,13 hitting the steepest levels of inversion since the early 1980s when the Fed was fighting double-digit inflation. Since July 2023, the yield curve has entered a bear steepening phase, with long-term rates increasing relative to short-term rates, eliminating the inversion while suggesting that both real growth and inflation could surprise on the low side of expectations. The Federal Reserve began increasing interest rates when year-over-year inflation in the Consumer Price Index (CPI)—a lagging economic indicator—reached 8.5% in March 2022. Shortly thereafter, geopolitical pressures and inventory hoarding pushed the CPI-based inflation rate to 9.1% on a year-over-year basis. Since then, CPI inflation has dropped to 2.5%,14  thanks to various deflationary forces––good, bad, and cyclical.

The Fed paused its tightening moves last summer. At the same time, in the technology realm, ChatGPT began to dramatize the seemingly miraculous breakthroughs that are likely to tip the scales even further toward broad-based deflation. Although creative destruction—the transition from gas-powered vehicles to electric vehicles, for example—could obfuscate the boom associated with AI and other disruptive technologies evolving today, the waves of growth associated with the convergence among the 14 technologies involved in our five major platforms—robotics, energy storage, AI, blockchain technology, and multiomics sequencing—should start moving the needle on macro metrics increasingly and significantly during the next five to ten years.

Meanwhile, earlier this year, the equity market reached a record-breaking level of concentration, spurring our search for diversified exposure to the AI revolution, particularly among software applications that our research suggests are underrepresented in broad-based benchmarks but likely to drive value creation over our investment horizon. In our view, history will show that inflation—initially triggered by supply shocks—was transitory and evolved into disinflation, then ultimately deflation. Consequently, interest rates are likely to surprise on the low side of expectations, broadening the equity rally from a narrow subset of stocks and reinforcing the need for diversified AI investments. If ARK is correct that the most important AI investment opportunities are associated with “disruptive innovation,” then the winners and losers are likely to be surprising, resulting in a more diverse set of winners to which current equity market concentration should give way.

During the third quarter of 2024, ARK's actively managed ETFs outperformed the broad-based global equity indexes.  That said, the indexed ETFs showed mixed results: one underperformed and one outperformed the S&P 500, and both lagged the MSCI World Index.

ARK Autonomous Technology and Robotics ETF (ARKQ)

The ARK Autonomous Technology and Robotics ETF (ARKQ) outperformed broad-based global equity indices during the quarter. Among the top contributors were Tesla (TSLA) and Rocket Lab (RKLB). Shares of Tesla contributed to performance after the company reported better-than-expected second-quarter vehicle deliveries and record stationary energy deployments. The stock lost some of its gains, however, after management delayed its robotaxi event from August to October, and the company missed analysts’ profit expectations for the second quarter. Separately, Tesla’s AI team released its roadmap for Full Self-Driving (FSD) software updates from now through the first quarter of 2025 and achieved all September milestones by quarter-end. Shares of Rocket Lab contributed to performance after the company reported its second-quarter earnings, highlighting the successful test of its Archimedes engine, which is set to power Neutron, its medium-lift reusable rocket, scheduled for its first launch in mid-2025. Later in the quarter, the company appointed Frank Klein, former Chief Operating Officer (COO) of Rivian, as its new COO and launched successfully its 53rd Electron mission.

Among top detractors were Teradyne (TER) and Archer Aviation (ACHR). Shares of Teradyne detracted from performance during the quarter amid a broad market pullback in semiconductor stocks. The company reported second-quarter earnings that beat analysts' expectations but guided for weaker-than-expected third-quarter earnings in anticipation of weakness in semiconductor testing for automotive, mobile, and industrial sectors. Shares of Archer Aviation detracted from performance during the quarter amid a broad market pullback in electric vertical take-off and landing (eVTOL) stocks. The company raised ~$230 million from investors and reached an agreement in principle with Stellantis to provide up to ~$400 million in additional funds to help scale its Midnight aircraft production. Archer also made significant operational progress, completing over 400 test flights this year and advancing its planned electric air taxi network in California.

ARK Next Generation Internet ETF (ARKW)

The ARK Next Generation Internet ETF (ARKW) outperformed broad-based global equity indices during the quarter. Among the top contributors were Tesla (TSLA), for the reasons discussed above, and Roku (ROKU). Shares of Roku contributed to performance during the quarter, thanks to the company’s robust second-quarter earnings. Roku added 2 million net streaming households, increasing its total to 83.6 million, while streaming hours surged by 20% year-over-year. In September, the company launched its new Ads Manager platform, a self-service performance solution that enables advertisers to create, manage, and measure their TV streaming ad campaigns directly on Roku's platform.

Among the top detractors were Coinbase (COIN) and PagerDuty (PD). Shares of Coinbase detracted from performance this quarter as its global digital asset trading volumes declined ~15% quarter-over-quarter. In addition to muted overall market activity, the Federal Reserve created a headwind to Coinbase's stablecoin-based interest income with a 50-basis point cut in the Fed funds rate and signals that more rates cuts are on the way. Shares of PagerDuty Inc. detracted from the fund this quarter after its management lowered full-year revenue guidance in anticipation of longer sales cycles associated with larger, multiyear contracts. That said, the company remains on track to achieve its targeted 10% annual recurring revenue (ARR) growth by the end of the year thanks to increased adoption of its AIOps16 and customer service products.

ARK Genomic Revolution ETF (ARKG)

The ARK Genomic Revolution ETF (ARKG) outperformed broad-based global equity indices during the quarter. Among the top contributors were CareDx (CDNA) and Personalis (PSNL). Shares of CareDx contributed to performance this quarter after the company reported 31% revenue growth year-over-year and raised full-year revenue guidance by 17% at the mid-point. The company got another tailwind as the Centers for Medicare and Medicaid Services (CMS) announced its plan to retire a previously drafted local coverage determination (LCD) that would have restricted coverage for non-invasive blood-based surveillance testing for allograft rejection. Combined with the February 2024 removal of restrictive language in the accompanying Billing Article and based on discussions with CMS, CareDx management suggested that longstanding coverage for AlloSure®, AlloMap® and HeartCare® has been restored. Shares of Personalis contributed to performance this quarter, thanks to a set of positive events. First, the company reported second-quarter earnings, including revenue growth of 35% year-over-year, thanks to increasing demand for its cancer-monitoring minimal residual disease (MRD) product, NeXT Personnel, as well as strong demand for its personalized cancer vaccine tumor profiling products. Management also increased revenue guidance for the year. Second, Tempus AI reported a 15.3% stake in Personalis and began an expanded partnership with Tempus AI to accelerate the commercialization of ultra-sensitive, tumor-informed minimal residual disease (MRD) tests on Tempus AI’s platform. Tempus AI will invest $36 million in Personalis and facilitate increased use of the tests for breast and lung cancers as well as in immunotherapy monitoring across all solid tumors.

Among the top detractors were Moderna (MRNA) and CRISPR Therapeutics (CRSP). Shares of Moderna detracted from performance this quarter after the company reported second-quarter earnings and lowered full-year product sales guidance from $4 billion to $3-3.5 billion, citing headwinds that include lower-than-expected uptake in sales of its COVID vaccine in the EU, increased competitive pressure in respiratory vaccines, and potential revenue deferrals from 2024 into 2025 for ex-EU and ex-US sales. That said, sales in the second quarter exceeded guidance, and management expects that new products and higher RSV vaccine penetration rates will restore the company’s growth in 2025. Shares of CRISPR Therapeutics detracted from performance this quarter in a broad-based market sell off in the gene editing space. We believe the market is underappreciating the significant revenue opportunity for the first commercialized gene editing therapy, Casgevy, which should generate revenue over the next six months.

ARK Fintech Innovation ETF (ARKF)

The ARK Fintech Innovation ETF (ARKF) outperformed broad-based global equity indices during the quarter. Among the top contributors were Shopify (SHOP) and Palantir (PLTR). Shares of Shopify contributed to the fund after the company reported second-quarter earnings, including revenue growth of 21% on a year-over-year basis that surpassed management’s guidance of high-teens growth. Shopify expanded its partnership with PayPal in the US by integrating PayPal wallet transactions with Shopify Payments through PayPal Complete Payments, creating a single, unified platform for Shopify merchants. Shares of Palantir Technologies Inc. contributed to the fund this quarter after posting strong second-quarter earnings. Palantir’s US commercial revenue growth accelerated from 40% to 55% year-over-year, as its Artificial Intelligence Platform (AIP) bootcamps continued to demonstrate value to customers. Government revenue, historically the core of Palantir's business, also saw revenue growth accelerate from 16% to 23%, prompting management to raise full-year guidance from 20.6% to 23.4%. Palantir's consistent profitability made it eligible for index inclusion, so Palantir joined the S&P 500 during the September reconstitution. Finally, Palantir also announced continued expansion in large government contracts, including a $100 million extension to its Maven Smart System contract with the US military.

Among the top detractors were Coinbase (COIN), for reasons discussed above, and Pinterest (PINS). Shares of Pinterest detracted from performance after the company reported second-quarter earnings that exceeded revenue expectations by 0.6% but issued third-quarter revenue guidance that fell short of consensus by 1.7%. Management noted challenging year-over-year comparisons and a foreign exchange headwind of 1 percentage point as key factors affecting their outlook.

ARK Space Exploration & Innovation ETF (ARKX)

The ARK Space Exploration & Innovation ETF (ARKX) outperformed broad-based global equity indices during the quarter. Among the top contributors were Rocket Lab (RKLB), for reasons discussed above, and Kratos Defense & Security (KTOS). Shares of Kratos Defense and Security contributed to performance as part of a broad market rally across defense stocks. During the quarter, the company reported better-than-expected second-quarter earnings supported by ~62% revenue growth in its unmanned systems segment. 

Among the top detractors were Mynaric (MYNA) and Teradyne (TER), the latter for reasons discussed above. Shares of Mynaric detracted from performance during the quarter after the company lowered its fiscal-year 2024 guidance in response to CONDOR Mk3 production delays that are forcing the company to seek additional capital. The company also announced that its Chief Financial Officer (CFO) and Chief Executive Officer (CEO) have left the organization. Consequently, the company brought on a Chief Restructuring Officer (CRO) to focus on reducing costs and near-term cash consumption.

ARK Innovation ETF (ARKK)

Invested in the highest conviction names in the Funds discussed above, the ARK Innovation ETF (ARKK) outperformed broad-based global equity indices during the quarter. Among the top contributors were Tesla (TSLA) and Roku (ROKU), for the reasons discussed above. Among the top detractors were Coinbase (COIN) and CRISPR Therapeutics (CRSP), for the reasons discussed above.

ARK Israel Innovation Technology ETF (IZRL) & The 3D Printing ETF (PRNT)

Among ARK’s self-indexed ETFs, the ARK Israel Innovation Technology ETF (IZRL) underperformed the broad-based global equity indices, and The 3D Printing ETF (PRNT) outperformed the S&P 500 but lagged the MSCI World Index.17

Shares of Alarum Technologies (ALAR) were the largest detractor from IZRL's performance during the quarter. Despite reporting year-over-year revenue growth of 27%, in line with expectations, shares sold off in tandem with management's weaker third-quarter expectations. Shares of Cellebrite (CLBT) were the largest contributor to IZRL’s performance this quarter after the company reported second-quarter earnings, including revenue growth of 25% year-over-year, thanks to subscription growth of 27% year-over-year. Cellebrite’s strong execution, along with total addressable market (TAM) expansion facilitated by the acquisition of Cyber Technology Services, prompted management to raise their full-year revenue, ARR, and EBITDA18 targets. 

Shares of Xometry (XMTR) were the largest contributor to PRNT’s performance during the quarter after the company reported better-than-expected second-quarter earnings. The company's AI-powered marketplace segment reported ~25% revenue growth and ~33% gross profit growth, thanks to increased demand across sectors like semiconductors, industrial equipment, consumer products, and aerospace and defense. Shares of Markforged (MKFG) were the largest detractor from PRNT’s performance during the quarter amid a broad market pullback across 3D printing stocks. In September, the company announced that it settled intellectual property litigation with Continuous Composites and that Nano Dimension had offered to acquire the company for $115 million, or $5 per share. 

ARK’s statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain of the statements contained may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements.

Explore ARK Funds

Featured Funds:

ARKQ Icon

ARK Autonomous Tech. & Robotics ETF

ARKW Icon

ARK Next Generation Internet ETF

ARKG Icon

ARK Genomic Revolution ETF

ARKK Icon

ARK Innovation ETF

PRNT Icon

The 3D Printing ETF

IZRL Icon

ARK Israel Innovative Technology ETF

ARKF Icon

ARK Fintech Innovation ETF

ARKX Icon

ARK Space Exploration & Innovation ETF

See All

ARK Trade Notifications

ARK offers fully transparent Exchange Traded Funds (“ETFs”) and provides investors with trade information for all actively managed ETFs.